Tolerability of long-term use of trabectedin (Tr) in combination with pegylated liposomal doxorubicin (PLD) in patients (pts) with relapsed ovarian cancer (ROC). Background: Our objective is to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results